Welcome to our dedicated page for Marathon Pete SEC filings (Ticker: MPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking refining margins across Marathon Petroleum’s 13-facility network shouldn’t require combing through hundreds of pages of technical disclosure. Yet each 10-K buries crack-spread data, environmental liabilities, and pipeline tariff details behind dense accounting language. That’s the pain point investors voice most often.
Our platform solves it. Stock Titan delivers AI-powered summaries that translate every Marathon Petroleum annual report 10-K simplified, Marathon Petroleum quarterly earnings report 10-Q filing, and Marathon Petroleum 8-K material events explained into plain English within minutes of hitting EDGAR. Real-time alerts flag Marathon Petroleum Form 4 insider transactions real-time, letting you monitor executive stock sales the same moment they’re filed. Need quick context? Just ask: “understanding Marathon Petroleum SEC documents with AI” and our system highlights which refinery turnaround or MPLX dropdown drives the numbers.
Every filing type is covered: proxy statements for Marathon Petroleum proxy statement executive compensation, insider forms for Marathon Petroleum insider trading Form 4 transactions, and 8-Ks for unplanned outages—all searchable, all linked to concise analytics. Use the data to compare quarter-over-quarter crack spreads, spot Marathon Petroleum executive stock transactions Form 4 before earnings, or dive into segment performance with our Marathon Petroleum earnings report filing analysis. Complex disclosures become actionable intelligence, enabling energy analysts, credit desks, and retail investors to act decisively without wading through footnotes.
Marathon Petroleum Corporation (MPC) has filed a Form 144 indicating a proposed sale of 7,392 common shares through Fidelity Brokerage Services on 3 July 2025 at the NYSE. Based on the quoted aggregate market value of $1.29 million, the implied price per share is approximately $175. The shares represent roughly 0.0024 % of the 307.2 million shares outstanding disclosed in the form. The shares were originally acquired via restricted-stock vesting on 1 April 2019 and are being sold for the account of an unidentified insider. No other sales were reported in the past three months, and no additional remarks, 10b5-1 plan information, or adverse disclosures accompany the notice.